Can a traditional pill help heart attack patients avoid future crises?
NCT ID NCT07153744
Summary
This large study is testing whether adding the Shexiang Baoxin Pill (MUSKARDIA) to standard care helps people who've just had a heart attack. It will involve nearly 10,000 patients who are getting a stent procedure. Researchers want to see if the pill reduces the risk of future heart problems, strokes, or hospital visits over the following year and helps patients feel better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERCUTANEOUS CORONARY INTERVENTION (PCI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongshan Hospital, Fudan University
Shanghai, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.